MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

dose, page-12

  1. 250 Posts.
    lightbulb Created with Sketch. 13
    Great response Jervalent...100% correct.

    the replication of the Phase 2a test in lab results in early 2005 explains a lot of the missing pieces.

    Still can't believe all of you would respond to Edward sh head.

    please hit the ignore button, as we really should just pretend this brainiac is invisible.

    2007 the year of MBP
 
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.